← Eichor
Study identifier: NCT02877706 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Condition: Immune Thrombocytopenia · Autoimmune Hemolytic Anemia  ·  Sponsor: University Hospital, Toulouse

PhaseN/A
Planned participants1500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

This description comes directly from the study's public registry record.

Talk to the study team

Moulis Guillaume, MD PhD  ·  moulis.g@chu-toulouse.fr

Johanne Germain, PhD  ·  johanne.germain@inserm.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Service de Médecine InterneToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02877706